Observational Study on the Patients With Pain Medications
- Conditions
- Pain
- Registration Number
- NCT00771212
- Lead Sponsor
- Johnson & Johnson Taiwan Ltd
- Brief Summary
The purpose of this study is to describe the use of pain treatments in Taiwan, the demographics, clinical characteristics of patients requiring pain treatments, current treatments, outcomes of treatments and the reasons for changing pain medication during treatment.
- Detailed Description
This is a Phase IV, multi-center, observational study to describe the use of pain treatments, the demographics, clinical characteristics of patients requiring pain treatments, current treatments, outcomes of treatments and the reasons for changing pain medication during treatment. The study is conducted in an effort to understand the status of pain control in Taiwan. Currently in Taiwan, there is no approved documentation showing the most effective standard medication for treatment of patients in pain. Observational study with no study medication administered.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2636
- Outpatients only
- Patients must have pain, previously treated with and without medication and have a VAS (Visual analogue scale) score recorded at the enrolment time
- Patient must have a VAS score >4
- Patients who are receiving any investigational drug during the study
- Patients with known or suspected psychotic disease or mental retardation.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To describe effective use of pain medications, describe demographics, clinical characteristics of patients requiring pain treatments, current treatments, outcomes of treatments and the reasons for changing pain medication during treatment in Taiwan 60 days
- Secondary Outcome Measures
Name Time Method Pain Relief Rating Scale 60 days Global Assessments (Patient/Investigator) 60 days Sleeping quality Assessment 60 days